Spectrofluorimetric determination of sertraline in dosage forms and human plasma through derivatization with 9-fluorenylmethyl chloroformate

Table 3 Validation of the proposed method for the determination of sertraline in pure form and tablets

Concentration added (μg mL^-1)	% Recovery	% RSD	% Error
SER
Intra-day
0.2	98.75 ± 0.65	0.65	0.33
0.4	100.41 ± 1.07	1.07	0.54
0.6	98.66 ± 0.5	0.5	0.25
Inter-day
0.2	99.98 ± 0.82	0.82	0.41
0.4	100.63 ± 0.85	0.85	0.43
0.6	100.74 ± 1.17	1.17	0.59
Lustral Tablets (50 mg SER/tablet)
Intra-day
0.2	98.00 ± 1.29	1.29	0.65
0.4	100.41 ± 0.92	0.92	0.46
0.6	100.47 ± 1.35	1.35	0.68
Inter-day
0.20	100.19 ± 1.07	1.07	0.54
0.40	99.67 ± 1.56	1.56	0.78
0.60	100.80 ± 0.80	0.80	0.40

ISSN: 2661-801X